Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2024

Open Access 01-12-2024 | Acute Kidney Injury | Research

JianPiYiShen formula prevents cisplatin-induced acute kidney injury in mice by improving necroptosis through MAPK pathway

Authors: Zhongtang Li, Riming He, Jiahui Liu, Xiaoming Jin, Beibei Jiang, Yunlan Lao, Shudong Yang

Published in: BMC Complementary Medicine and Therapies | Issue 1/2024

Login to get access

Abstract

Background

Acute kidney injury (AKI), characterized by necroptosis and activation of MAPK pathway, causes sudden declines in renal function. To date, efficacious treatments are lacking. JianPiYiShen Formula (JPYSF) has a protective effect on the kidneys. The aim of this study is to explore the mechanism of JPYSF in cisplatin-induced AKI.

Methods

Male C57/BL6J mice were divided into control group, cisplatin group and cisplatin + JPYSF group. Before establishing the model, the cisplatin + JPYSF group was administered JPYSF (18.35 g/kg/day) by gavage for 5 consecutive days. A single intraperitoneal injection of cisplatin (20 mg/kg) was used to establish AKI model. Measurement of renal function and H&E staining were performed to assess renal damage. WB, PCR, TUNEL staining and immunohistochemistry were used to detect related indicators of mitochondrial function, oxidative stress, necroptosis, inflammation and MAPK pathway. And one-way analysis of variance was used to compare group differences.

Results

Compared with the cisplatin group, JPYSF can attenuate AKI, reflected by the decrease in Scr and BUN levels, the improvement of renal tubular injury, and the downregulation of NGAL and KIM1. Cisplatin can induce mitochondrial dysfunction and oxidative stress, triggering necroptosis. In this study, JPYSF improved mitochondrial dysfunction to enhance oxidative stress, as manifested by upregulation of OPA1, PGC-1α, SOD and CAT, and downregulation of DRP1 and MFF. Then JPYSF showed a significant protective effect in necroptosis, as embodied by reduced number of TUNEL-positive cells, decreased the gene expression of RIPK3 and MLKL, as well as downregulation the proteins expression of P-RIPK1, P-RIPK3, and P-MLKL. Moreover, necroptosis can aggravate inflammation. JPYSF ameliorated inflammation by improving inflammatory and anti-inflammatory indexes, including downregulation of TNF-α, IL-6, MCP-1 and LY6G, and upregulation of IL-10. In addition, JPYSF also inhibited MAPK pathway to improve necroptosis by decreasing the expression of P-JNK and P-ERK.

Conclusion

Our data showed that JPYSF prevents cisplatin-induced AKI by improving necroptosis through MAPK pathway, which is related to the improvement of mitochondrial dysfunction, oxidative stress, and inflammation.
Appendix
Available only for authorised users
Literature
2.
go back to reference Fang Cyan, Lou D, yong, Zhou L, qin, Wang Jcheng, Yang B, He Q. Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin. 2021;42(12):1951–69.CrossRefPubMedPubMedCentral Fang Cyan, Lou D, yong, Zhou L, qin, Wang Jcheng, Yang B, He Q. Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin. 2021;42(12):1951–69.CrossRefPubMedPubMedCentral
3.
go back to reference Mcsweeney KR, Gadanec LK, Zulli A. Mechanisms of Cisplatin-Induced Acute kidney Injury. Cancers (Basel). 2021;13(1572):1–42. Mcsweeney KR, Gadanec LK, Zulli A. Mechanisms of Cisplatin-Induced Acute kidney Injury. Cancers (Basel). 2021;13(1572):1–42.
4.
go back to reference Liu X, Li L, Ding X, Ren Y, Zhang L, Shao Z. The role of necroptosis in disease and treatment. 2021;(November):730–55. Liu X, Li L, Ding X, Ren Y, Zhang L, Shao Z. The role of necroptosis in disease and treatment. 2021;(November):730–55.
5.
8.
go back to reference Mulay SR, Linkermann A, Anders HJ. Necroinflammation in kidney disease. J Am Soc Nephrol. 2016;27(1):27–39.CrossRefPubMed Mulay SR, Linkermann A, Anders HJ. Necroinflammation in kidney disease. J Am Soc Nephrol. 2016;27(1):27–39.CrossRefPubMed
9.
go back to reference Muraro SP, De Souza GF, Gallo SW, Da Silva BK, De Oliveira SD, Vinolo MAR, et al. Respiratory Syncytial Virus induces the classical ROS-dependent NETosis through PAD-4 and necroptosis pathways activation. Sci Rep. 2018;8(1):1–12.ADSCrossRef Muraro SP, De Souza GF, Gallo SW, Da Silva BK, De Oliveira SD, Vinolo MAR, et al. Respiratory Syncytial Virus induces the classical ROS-dependent NETosis through PAD-4 and necroptosis pathways activation. Sci Rep. 2018;8(1):1–12.ADSCrossRef
10.
go back to reference Alassaf N, Attia H. Autophagy and necroptosis in cisplatin-induced acute kidney injury: recent advances regarding their role and therapeutic potential. Front Pharmacol. 2023;14(January). Alassaf N, Attia H. Autophagy and necroptosis in cisplatin-induced acute kidney injury: recent advances regarding their role and therapeutic potential. Front Pharmacol. 2023;14(January).
12.
go back to reference Zhang Y, Su SS, Zhao S, Yang Z, Zhong CQ, Chen X et al. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun [Internet]. 2017;8(May 2016):1–14. https://doi.org/10.1038/ncomms14329. Zhang Y, Su SS, Zhao S, Yang Z, Zhong CQ, Chen X et al. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun [Internet]. 2017;8(May 2016):1–14. https://​doi.​org/​10.​1038/​ncomms14329.
13.
go back to reference Fan Y, Lu J, Yu Z, Qu X, Guan S. 1,3-Dichloro-2-propanol-induced renal tubular cell necroptosis through the ROS/RIPK3/MLKL pathway. J Agric Food Chem. 2022;70(35):10847–57.CrossRefPubMed Fan Y, Lu J, Yu Z, Qu X, Guan S. 1,3-Dichloro-2-propanol-induced renal tubular cell necroptosis through the ROS/RIPK3/MLKL pathway. J Agric Food Chem. 2022;70(35):10847–57.CrossRefPubMed
14.
go back to reference Al Shahrani M, Chandramoorthy HC, Alshahrani M, Abohassan M, Eid RA, Ravichandran K, et al. Cassia auriculata leaf extract ameliorates diabetic nephropathy by attenuating autophagic necroptosis via RIP-1/RIP-3-p-p38MAPK signaling. J Food Biochem. 2021;45(7):1–12.CrossRef Al Shahrani M, Chandramoorthy HC, Alshahrani M, Abohassan M, Eid RA, Ravichandran K, et al. Cassia auriculata leaf extract ameliorates diabetic nephropathy by attenuating autophagic necroptosis via RIP-1/RIP-3-p-p38MAPK signaling. J Food Biochem. 2021;45(7):1–12.CrossRef
15.
19.
go back to reference Sipieter F, Cappe B, Leray A, De Schutter E, Bridelance J, Hulpiau P et al. Characteristic ERK1/2 signaling dynamics distinguishes necroptosis from apoptosis. iScience. 2021;24(9). Sipieter F, Cappe B, Leray A, De Schutter E, Bridelance J, Hulpiau P et al. Characteristic ERK1/2 signaling dynamics distinguishes necroptosis from apoptosis. iScience. 2021;24(9).
21.
go back to reference Zhao Y, Li X, Wang F, Huang S, Du H, Li S, et al. Network Pharmacology and Experimental Verification Strategies to illustrate the mechanism of Jian-Pi-Yi-Shen Formula in suppressing epithelial–mesenchymal transition. Front Pharmacol. 2022;13(May):1–12. Zhao Y, Li X, Wang F, Huang S, Du H, Li S, et al. Network Pharmacology and Experimental Verification Strategies to illustrate the mechanism of Jian-Pi-Yi-Shen Formula in suppressing epithelial–mesenchymal transition. Front Pharmacol. 2022;13(May):1–12.
22.
go back to reference Liu X, Liu S, Zhang B, Luo D, Huang S, Wang F et al. Jian-Pi-Yi-Shen Formula Alleviates Chronic Kidney Disease in Two Rat Models by Modulating QPRT/NAD+/SIRT3/Mitochondrial Dynamics Pathway. Evidence-based Complementary and Alternative Medicine. 2021;2021. Liu X, Liu S, Zhang B, Luo D, Huang S, Wang F et al. Jian-Pi-Yi-Shen Formula Alleviates Chronic Kidney Disease in Two Rat Models by Modulating QPRT/NAD+/SIRT3/Mitochondrial Dynamics Pathway. Evidence-based Complementary and Alternative Medicine. 2021;2021.
23.
go back to reference He R, Liu J, Chen Y, Liao Y, Wang Y, Jin X et al. A Chinese Medicine Compound Alleviates Cisplatin-Induced Acute Kidney Injury via Its Antiapoptosis and Anti-Inflammation Effects in Mice. Evidence-based Complementary and Alternative Medicine. 2022;2022. He R, Liu J, Chen Y, Liao Y, Wang Y, Jin X et al. A Chinese Medicine Compound Alleviates Cisplatin-Induced Acute Kidney Injury via Its Antiapoptosis and Anti-Inflammation Effects in Mice. Evidence-based Complementary and Alternative Medicine. 2022;2022.
24.
go back to reference Zhou F, Zou X, Zhang J, Wang Z, Yang Y, Wang D. Jian-Pi-Yi-Shen Formula ameliorates oxidative stress, inflammation, and apoptosis by activating the Nrf2 Signaling in 5/6 nephrectomized rats. Front Pharmacol. 2021;12(March):1–12. Zhou F, Zou X, Zhang J, Wang Z, Yang Y, Wang D. Jian-Pi-Yi-Shen Formula ameliorates oxidative stress, inflammation, and apoptosis by activating the Nrf2 Signaling in 5/6 nephrectomized rats. Front Pharmacol. 2021;12(March):1–12.
25.
go back to reference Wei W, Wu X, Li J. Dosage issues in pharmacological experimental design in experimental methodology of Pharmacology. China: Academic; 2010. pp. 69–74. Wei W, Wu X, Li J. Dosage issues in pharmacological experimental design in experimental methodology of Pharmacology. China: Academic; 2010. pp. 69–74.
27.
go back to reference Shi L, Song Z, Li C, Deng F, Xia Y, Huang J et al. HDAC6 inhibition alleviates ischemia- and Cisplatin-Induced Acute kidney Injury by promoting Autophagy. Cells. 2022;11(24). Shi L, Song Z, Li C, Deng F, Xia Y, Huang J et al. HDAC6 inhibition alleviates ischemia- and Cisplatin-Induced Acute kidney Injury by promoting Autophagy. Cells. 2022;11(24).
28.
go back to reference Blainey P, Krzywinski M, Altman N. Points of significance: replication. Nat Methods. 2014;11(9):879–80.CrossRefPubMed Blainey P, Krzywinski M, Altman N. Points of significance: replication. Nat Methods. 2014;11(9):879–80.CrossRefPubMed
29.
30.
go back to reference Ciarimboli G, Ludwig T, Lang D, Pavenstädt H, Koepsell H, Piechota HJ, et al. Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol. 2005;167(6):1477–84.CrossRefPubMedPubMedCentral Ciarimboli G, Ludwig T, Lang D, Pavenstädt H, Koepsell H, Piechota HJ, et al. Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol. 2005;167(6):1477–84.CrossRefPubMedPubMedCentral
31.
32.
go back to reference Ortega-Domínguez B, Aparicio-Trejo OE, García-Arroyo FE, León-Contreras JC, Tapia E, Molina-Jijón E, et al. Curcumin prevents cisplatin-induced renal alterations in mitochondrial bioenergetics and dynamic. Food Chem Toxicol. 2017;107:373–85.CrossRefPubMed Ortega-Domínguez B, Aparicio-Trejo OE, García-Arroyo FE, León-Contreras JC, Tapia E, Molina-Jijón E, et al. Curcumin prevents cisplatin-induced renal alterations in mitochondrial bioenergetics and dynamic. Food Chem Toxicol. 2017;107:373–85.CrossRefPubMed
33.
go back to reference Shen D, Guo M, Geng X, Yu J, Zhang Z, Lin J, et al. Magnesium Lithospermate B protects against Cisplatin-Induced Acute kidney Injury via alleviating mitochondrial dysfunction. Drug Des Devel Ther. 2022;16(January):2293–304.CrossRefPubMedPubMedCentral Shen D, Guo M, Geng X, Yu J, Zhang Z, Lin J, et al. Magnesium Lithospermate B protects against Cisplatin-Induced Acute kidney Injury via alleviating mitochondrial dysfunction. Drug Des Devel Ther. 2022;16(January):2293–304.CrossRefPubMedPubMedCentral
34.
go back to reference Zhou M, Dai Y, Ma Y, Yan Y, Hua M, Gao Q et al. Article Protective effects of Liquiritigenin against Cisplatin-Induced Nephrotoxicity via NRF2/SIRT3-Mediated improvement of mitochondrial function. Molecules. 2022;27(12). Zhou M, Dai Y, Ma Y, Yan Y, Hua M, Gao Q et al. Article Protective effects of Liquiritigenin against Cisplatin-Induced Nephrotoxicity via NRF2/SIRT3-Mediated improvement of mitochondrial function. Molecules. 2022;27(12).
35.
go back to reference Kim JS, Kim KS, Son JY, Kim HR, Park JH, Lee SH et al. Protective effects of Dendropanax morbifera against cisplatin-induced nephrotoxicity without altering chemotherapeutic efficacy. Antioxidants. 2019;8(8). Kim JS, Kim KS, Son JY, Kim HR, Park JH, Lee SH et al. Protective effects of Dendropanax morbifera against cisplatin-induced nephrotoxicity without altering chemotherapeutic efficacy. Antioxidants. 2019;8(8).
37.
go back to reference Manohar S, Leung N. Cisplatin nephrotoxicity: a review of the literature. J Nephrol. 2018;31(1):15–25.CrossRefPubMed Manohar S, Leung N. Cisplatin nephrotoxicity: a review of the literature. J Nephrol. 2018;31(1):15–25.CrossRefPubMed
38.
go back to reference Gwon MG, Gu H, Leem J, Park KK. Protective effects of 6-shogaol, an active compound of ginger, in a murine model of cisplatin-induced acute kidney injury. Molecules. 2021;26(19). Gwon MG, Gu H, Leem J, Park KK. Protective effects of 6-shogaol, an active compound of ginger, in a murine model of cisplatin-induced acute kidney injury. Molecules. 2021;26(19).
39.
go back to reference Xiao X, Du C, Yan Z, Shi Y, Duan H, Ren Y. Inhibition of necroptosis attenuates kidney inflammation and interstitial Fibrosis Induced by Unilateral Ureteral obstruction. Am J Nephrol. 2017;46(2):131–8.CrossRefPubMed Xiao X, Du C, Yan Z, Shi Y, Duan H, Ren Y. Inhibition of necroptosis attenuates kidney inflammation and interstitial Fibrosis Induced by Unilateral Ureteral obstruction. Am J Nephrol. 2017;46(2):131–8.CrossRefPubMed
40.
go back to reference Rungelrath V, Kobayashi SD, DeLeo FR. Neutrophils in innate immunity and systems biology-level approaches. Wiley Interdiscip Rev Syst Biol Med. 2020;12(1):1–30.CrossRef Rungelrath V, Kobayashi SD, DeLeo FR. Neutrophils in innate immunity and systems biology-level approaches. Wiley Interdiscip Rev Syst Biol Med. 2020;12(1):1–30.CrossRef
41.
go back to reference Wu Y, Yang B. Erythropoietin Receptor/β common receptor: a shining light on acute kidney Injury Induced by Ischemia-Reperfusion. Front Immunol. 2021;12(June):1–11. Wu Y, Yang B. Erythropoietin Receptor/β common receptor: a shining light on acute kidney Injury Induced by Ischemia-Reperfusion. Front Immunol. 2021;12(June):1–11.
Metadata
Title
JianPiYiShen formula prevents cisplatin-induced acute kidney injury in mice by improving necroptosis through MAPK pathway
Authors
Zhongtang Li
Riming He
Jiahui Liu
Xiaoming Jin
Beibei Jiang
Yunlan Lao
Shudong Yang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2024
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-024-04366-9

Other articles of this Issue 1/2024

BMC Complementary Medicine and Therapies 1/2024 Go to the issue